Ítem
Solo Metadatos

Pathophysiological mechanisms of cognitive impairment and neurodegeneration bt Toxoplasma gondii infection

dc.creatorOrtiz-Guerrero, Gloriaspa
dc.creatorGonzález Reyes, Rodrigo Estebanspa
dc.creatorde-la-Torre, Alejandraspa
dc.creatorMedina-Rincón, Germanspa
dc.creatorNava Mesa, Mauricio Orlandospa
dc.date.accessioned2020-08-28T15:48:16Z
dc.date.available2020-08-28T15:48:16Z
dc.date.created2020-06-12spa
dc.description.abstractToxoplasma gondii is an obligate intracellular parasite considered one of the most successful pathogens in the world, owing to its ability to produce long-lasting infections and to persist in the central nervous system (CNS) in most warm-blooded animals, including humans. This parasite has a preference to invade neurons and a ect the functioning of glial cells. This could lead to neurological and behavioral changes associated with cognitive impairment. Although several studies in humans and animal models have reported controversial results about the relationship between toxoplasmosis and the onset of dementia as a causal factor, two recent meta-analyses have shown a relative association with Alzheimer’s disease (AD). AD is characterized by amyloid- (A ) peptide accumulation, neurofibrillary tangles, and neuroinflammation. Di erent authors have found that toxoplasmosis may a ect A production in brain areas linked with memory functioning, and can induce a central immune response and neurotransmitter imbalance, which in turn, a ect the nervous system microenvironment. In contrast, other studies have revealed a reduction of A plaques and hyperphosphorylated tau protein formation in animal models, which might cause some protective e ects. The aim of this article is to summarize and review the newest data in regard to di erent pathophysiological mechanisms of cerebral toxoplasmosis and their relationship with the development of AD and cognitive impairment. All these associations should be investigated further through clinical and experimental studies.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.3390/brainsci10060369
dc.identifier.issnEISSN: 2076-3425
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/28469
dc.language.isoengspa
dc.publisherMDPI AGspa
dc.relation.citationIssueNo. 6
dc.relation.citationTitleBrain Sciences
dc.relation.citationVolumeVol. 10
dc.relation.ispartofBrain Sciences, EISSN: 2076-3425, Vol. 10, No. 6 (2020); 19 pp.spa
dc.relation.urihttps://www.mdpi.com/2076-3425/10/6/369spa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.sourceBrain Sciencesspa
dc.source.instnameinstname:Universidad del Rosario
dc.source.reponamereponame:Repositorio Institucional EdocUR
dc.subject.keywordToxoplasma gondiispa
dc.subject.keywordAlzheimer’s diseasespa
dc.subject.keywordAmyloid-betaspa
dc.subject.keywordDementiaspa
dc.subject.keywordCognitive impairmentspa
dc.titlePathophysiological mechanisms of cognitive impairment and neurodegeneration bt Toxoplasma gondii infectionspa
dc.title.TranslatedTitleMecanismos fisiopatológicos del deterioro cognitivo y la neurodegeneración por infección por Toxoplasma gondiispa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones